KRN7000 applied to melanoma research

Targeting NKT cells and PD-L1 pathway results in augmented anti-tumor responses in a melanoma model

Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells

Potentiation of antitumor effect of NKT cell ligand, alpha-galactosylceramide by combination with IL-12 on lung metastasis of malignant melanoma cells

In vitro anti-tumour activity of alpha-galactosylceramide-stimulated human invariant Valpha24+NKT cells against melanoma

 

Meet Funakoshi Company

Please visit our booth at:

NIH Research Festival
October 11-12, 2012
Booth# 566